Secondary Prophylaxis of Docetaxel Induced Diarrhea with Loperamide: Case Report.
10.3346/jkms.2013.28.10.1549
- Author:
Hee Yeon LEE
1
;
Youn Hee LEE
;
Min Ji KIM
;
Hoon Kyo KIM
Author Information
1. Division of Medical Oncology, Department of Internal Medicine, St. Vincent's Hospital, The Catholic University of Korea, Suwon, Korea. miongsok@catholic.ac.kr
- Publication Type:Case Reports
- Keywords:
Docetaxel;
Diarrhea;
Loperamide
- MeSH:
Aged;
Carcinoma, Non-Small-Cell Lung/*drug therapy/radiography;
Cisplatin/therapeutic use;
Diarrhea/chemically induced/*etiology;
Drug Therapy, Combination;
Humans;
Loperamide/*adverse effects/therapeutic use;
Lung Neoplasms/*drug therapy/radiography;
Male;
Neoplasm Staging;
Taxoids/*adverse effects/therapeutic use;
Tomography, X-Ray Computed
- From:Journal of Korean Medical Science
2013;28(10):1549-1551
- CountryRepublic of Korea
- Language:English
-
Abstract:
Diarrhea is a common adverse event of docetaxel with 20%-40% of incidence and severe diarrhea occurs in 5%-6%. Several treatment guidelines for chemotherapy induced diarrhea (CID) exist, however the prophylaxis for that is not well known. We describe a new prophylactic approach for the CID with loperamide. A 72-yr-old male patient with stage IV non-small-cell lung cancer developed diarrhea repeatedly after docetaxel-cisplatin chemotherapy. His diarrhea persisted despite treatment including loperamide and fasting. However, the diarrhea was successfully prevented when loperamide was given before and after the chemotherapy. To our knowledge, this is the first report of prophylactic approach for the CID with loperamide.
